Cognoptix, a privately held medical technology company headquartered in Acton, Mass., is focused on developing and commercializing an in-office, drug/device diagnostic system as an aid in the early detection of Alzheimers Disease (AD). Its lead investor is Inventages Venture Capital, one of the worlds largest life sciences-, nutrition- and wellness-focused venture capital firms.